Cargando…

Antioxidant therapy in the management of fluoroquinolone-associated disability

Detalles Bibliográficos
Autores principales:	Pietruszyński, Robert, Pietruszyńska-Reszetarska, Agnieszka, Sokal, Jan, Domżalski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667412/ https://www.ncbi.nlm.nih.gov/pubmed/33224355 http://dx.doi.org/10.5114/aoms.2019.82717

Ejemplares similares

Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications
por: Michalak, Krzysztof, et al.
Publicado: (2017)

Factors Influencing Fluoroquinolone Resistance
por: Sahm, Daniel F., et al.
Publicado: (2003)

Fluoroquinolone Use in Food Animals
por: Collignon, Peter
Publicado: (2005)

Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006)

Fluoroquinolone-Resistant Typhoid, South Africa
por: Keddy, Karen H., et al.
Publicado: (2010)

Fluoroquinolone-resistant Salmonella Paratyphi A
por: Adachi, Takuya, et al.
Publicado: (2005)

Fluoroquinolone-resistant Salmonella sp. in Carcasses
por: Wang, Yu-Chih, et al.
Publicado: (2006)

Fluoroquinolones: An under-recognized cause for delirium
por: Chowdhry, Vivek, et al.
Publicado: (2015)

Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France
por: Le Roy, Chloé, et al.
Publicado: (2016)

In the Quest of Drugs for Bad Bugs: Are Newer Fluoroquinolones Any Better?
por: Deep, Antariksh, et al.
Publicado: (2011)

Fluoroquinolone-Resistant Group B Streptococci in Acute Exacerbation of Chronic Bronchitis
por: Tazi, Asmaa, et al.
Publicado: (2008)

gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027
por: Drudy, Denise, et al.
Publicado: (2007)

Fluoroquinolone preventive therapy for children exposed to MDR-TB
por: Gureva, T., et al.
Publicado: (2022)

Evaluation of disability in patients exposed to fluoroquinolones
por: Wilcox, Marsha A., et al.
Publicado: (2020)

Assessment of Disability and Factors Determining Disability among Inhabitants of South-Eastern Poland Aged 71–80 Years
por: Ćwirlej-Sozańska, Agnieszka, et al.
Publicado: (2018)

Determinants of ADL and IADL disability in older adults in southeastern Poland
por: Ćwirlej-Sozańska, Agnieszka, et al.
Publicado: (2019)

Discovery of a Fluoroquinolone-Resistant Serratia marcescens Clinical Isolate without Quinolone Resistance-Determining Region Mutations
por: Yang, Haifei, et al.
Publicado: (2014)

Chromosomal Locations of mcr-1 and bla(CTX-M-15) in Fluoroquinolone-Resistant Escherichia coli ST410
por: Falgenhauer, Linda, et al.
Publicado: (2016)

Analysis of Chronic Illnesses and Disability in a Community-Based Sample of Elderly People in South-Eastern Poland
por: Ćwirlej-Sozańska, Agnieszka, et al.
Publicado: (2018)

Trend of disability prevalence in Iran: An evidence to improve disability data
por: Soltani, Shahin, et al.
Publicado: (2015)

Disability Certification in India: Indian Disability Evaluation and Assessment Scale versus World Health Organization Disability Assessment Schedule
por: Basavarajappa, Chethan, et al.
Publicado: (2017)

Antioxidant Therapy for Atrial Fibrillation: What Is the Next Step?
por: Sovari, Ali A.
Publicado: (2011)

A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders
por: Cannizzaro, Deanna N., et al.
Publicado: (2021)

Fluoroquinolone-Resistant Mycobacterium tuberculosis, Pakistan, 2005–2009
por: Jabeen, Kauser, et al.
Publicado: (2011)

Intellectual disabilities and yoga
por: Singh, Satendra
Publicado: (2013)

Disability and Psychiatric Disorders
por: Singh, Darpan Kaur Mohinder, et al.
Publicado: (2012)

Prevalence of Disability in Iran
por: SOLTANI, Shahin, et al.
Publicado: (2015)

Disabled and the Employment Tax
por: Bailey, K. C.
Publicado: (1966)

Nymphomania with intellectual disability
por: Sharma, Mini, et al.
Publicado: (2022)

Response to article: Behavioral management in children with intellectual disabilities in a resource-poor setting in Barwani, India
por: Bansal, Shwetank, et al.
Publicado: (2014)

Minimising disability in stroke survivors
por: Dalal, P. M., et al.
Publicado: (2009)

Disability certification in Digital India
por: Gupta, Harish
Publicado: (2022)

Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
por: Agarwal, Ritesh
Publicado: (2006)

Fluoroquinolones compared to 1% azithromycin in DuraSite(®) for bacterial conjunctivitis
por: Lichtenstein, Steven J, et al.
Publicado: (2008)

Concomitant prescription of oral fluoroquinolones with an antacid preparation
por: Jhaj, Ratinder, et al.
Publicado: (2013)

Antioxidant trials—the need to test for stress
por: Aitken, Robert John
Publicado: (2021)

Prescription cascading in developmentally disabled individuals
por: Patel, Isha, et al.
Publicado: (2016)

Mobile Application for Orthopedic Disability Assessment
por: Agarwal, Ankur, et al.
Publicado: (2019)

Quinolones and fluoroquinolones are useless to counter uropathogenic Escherichia coli infections [Letter]
por: Singh, Bhoj R
Publicado: (2019)

Interleukin-6 and statin therapy: potential role in the management of COPD
por: Young, Robert P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_or4srd3102s05u4m2i3hqdl22a